↓ Skip to main content

Retracted: Comparison of Central versus Peripheral Delivery of Pregabalin in Neuropathic Pain States

Overview of attention for article published in Molecular Pain, January 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Retracted: Comparison of Central versus Peripheral Delivery of Pregabalin in Neuropathic Pain States
Published in
Molecular Pain, January 2012
DOI 10.1186/1744-8069-8-3
Pubmed ID
Authors

Jose A Martinez, Manami Kasamatsu, Alma Rosales-Hernandez, Leah R Hanson, William H Frey, Cory C Toth

Abstract

Although pregabalin therapy is beneficial for neuropathic pain (NeP) by targeting the CaVα2δ-1 subunit, its site of action is uncertain. Direct targeting of the central nervous system may be beneficial for the avoidance of systemic side effects.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
Germany 1 2%
Unknown 50 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 15%
Student > Master 8 15%
Researcher 7 13%
Other 6 12%
Professor 4 8%
Other 12 23%
Unknown 7 13%
Readers by discipline Count As %
Medicine and Dentistry 17 33%
Agricultural and Biological Sciences 13 25%
Neuroscience 2 4%
Psychology 2 4%
Philosophy 1 2%
Other 7 13%
Unknown 10 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2012.
All research outputs
#20,656,820
of 25,374,647 outputs
Outputs from Molecular Pain
#477
of 669 outputs
Outputs of similar age
#203,874
of 250,100 outputs
Outputs of similar age from Molecular Pain
#37
of 47 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 669 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,100 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.